Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use.
Saved in:
| Title: | Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use. |
|---|---|
| Authors: | Dao K; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Buettcher M; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland.; Pediatric Infectious Diseases, Children's Hospital of Central Switzerland (KidZ), Lucerne, Switzerland.; Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland., Golhen K; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland., Kost J; Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland., Schittny A; Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland., Duthaler U; Division of Clinical Pharmacology & Toxicology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Division of Clinical Pharmacology & Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Atkinson A; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland.; Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, MO, USA., Haefliger D; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Guidi M; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Bardinet C; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Chtioui H; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Boulekbache A; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Buclin T; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Huwyler J; Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland., Pfister M; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland., Rothuizen LE; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2024 Oct; Vol. 64 (10), pp. 1295-1303. Date of Electronic Publication: 2024 May 30. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-4604 |
|---|---|
| DOI: | 10.1002/jcph.2462 |
